Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
Cadrenal launches strategic review for cardiology pipeline
The biotech’s board is weighing options that could include selling drug candidates, partnering with other companies or even pursuing a merger.
Darren Incorvaia
Oct 7, 2026 12:54pm
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
Sep 1, 2026 9:59am
Blocked by FDA, Passage cuts headcount by 75%
May 4, 2026 1:33pm
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot
Mar 11, 2026 10:30am
MindMaze seeks 'strategic alternatives,' eyes US expansion
Mar 3, 2026 9:25am
Charles River sells CDMO and discovery assets in strategic pivot
Feb 25, 2026 1:54pm
